TY - JOUR AU - Brenner, B. M. AU - Cooper, M. E. AU - de Zeeuw, D. AU - Keane, W. K. AU - Mitch, W. E. AU - Parving, H. H. AU - Remuzzi, G. AU - Snapinn, S. M. AU - Zhang, Z. AU - Shahinfar, S. PY - 2001 DA - 2001// TI - Effects of losartan on renal ands cardiovascular outcomes in patients with type 2 diabetes and nephropathy. JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa011161 DO - 10.1056/NEJMoa011161 ID - Brenner2001 ER - TY - JOUR AU - Skali, H. AU - Solomon, S. D. AU - Pfeffer, M. A. PY - 2002 DA - 2002// TI - Are we asking too much of our trials? JO - Am Heart VL - 143 UR - https://doi.org/10.1067/mhj.2002.119771 DO - 10.1067/mhj.2002.119771 ID - Skali2002 ER - TY - JOUR AU - Fisman, E. Z. AU - Motro, M. AU - Tenenbaum, A. AU - Boyko, V. AU - Mandelzweig, L. AU - Behar, S. PY - 2001 DA - 2001// TI - Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis. JO - Am Heart J VL - 41 UR - https://doi.org/10.1067/mhj.2001.113219 DO - 10.1067/mhj.2001.113219 ID - Fisman2001 ER - TY - JOUR AU - McCulloch, D. K. AU - Glasgow, R. E. AU - Hampson, S. E. AU - Wagner, E. PY - 1994 DA - 1994// TI - A systemic approach to diabetes management in the post-DCCT era. JO - Diabetes Care VL - 17 UR - https://doi.org/10.2337/diacare.17.7.765 DO - 10.2337/diacare.17.7.765 ID - McCulloch1994 ER - TY - JOUR AU - Tenenbaum, A. AU - Fisman, E. Z. AU - Boyko, V. AU - Goldbourt, U. AU - Graff, E. AU - Shemesh, J. AU - Shotan, A. AU - Reicher-Reiss, H. AU - Behar, S. AU - Motro, M. PY - 1999 DA - 1999// TI - Hypertension in diet versus pharmacologically treated diabetics: mortality over a 5-year follow-up. JO - Hypertension VL - 33 UR - https://doi.org/10.1161/01.HYP.33.4.1002 DO - 10.1161/01.HYP.33.4.1002 ID - Tenenbaum1999 ER - TY - JOUR AU - Brady, P. A. AU - Terzic, A. PY - 1998 DA - 1998// TI - The sulfonylurea controversy: more questions from the heart. JO - J Am Coll Cardiol VL - 31 UR - https://doi.org/10.1016/S0735-1097(98)00038-2 DO - 10.1016/S0735-1097(98)00038-2 ID - Brady1998 ER - TY - JOUR AU - Fisman, E. Z. AU - Tenenbaum, A. AU - Boyko, V. AU - Benderly, M. AU - Adler, Y. AU - Friedensohn, A. AU - Kohanovski, M. AU - Rotzak, R. AU - Schneider, H. AU - Behar, S. AU - Motro, M. PY - 2001 DA - 2001// TI - Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up. JO - Clin Cardiol VL - 24 UR - https://doi.org/10.1002/clc.4960240210 DO - 10.1002/clc.4960240210 ID - Fisman2001 ER - TY - JOUR AU - Olsson, J. AU - Lindberg, G. AU - Gottsater, M. AU - Lindwall, K. AU - Sjostrand, A. AU - Tisell, A. AU - Melander, A. PY - 2000 DA - 2000// TI - Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study. JO - Diabetologia VL - 43 UR - https://doi.org/10.1007/s001250051343 DO - 10.1007/s001250051343 ID - Olsson2000 ER - TY - JOUR AU - Yusuf, S. AU - Negassa, A. PY - 2002 DA - 2002// TI - Choice of clinical outcomes in randomized trials of heart failure therapies: Disease-specific or overall outcomes? JO - Am Heart J VL - 143 UR - https://doi.org/10.1067/mhj.2002.119770 DO - 10.1067/mhj.2002.119770 ID - Yusuf2002 ER - TY - JOUR AU - O'Connor, C. M. AU - Gattis, W. A. AU - Ryan, T. J. PY - 2000 DA - 2000// TI - The role of clinical nonfatal end points in cardiovascular phase II/III clinical trials. JO - Am Heart J VL - 139 UR - https://doi.org/10.1016/S0002-8703(00)90062-0 DO - 10.1016/S0002-8703(00)90062-0 ID - O'Connor2000 ER - TY - CHAP PY - 1992 DA - 1992// TI - New drug, antibiotic and biological drug product regulations: accelerated approval. Proposed rule. BT - 57 Federal Register 13234–13242, Washington ID - ref11 ER - TY - JOUR AU - Temple, R. PY - 1999 DA - 1999// TI - Are surrogate markers adequate to assess cardiovascular disease drugs? JO - JAMA VL - 282 UR - https://doi.org/10.1001/jama.282.8.790 DO - 10.1001/jama.282.8.790 ID - Temple1999 ER - TY - CHAP AU - Denker, B. M. AU - Brenner, B. M. ED - Fauci, A. S. ED - Braunwald, E. ED - Isselbacher, K. J. PY - 1998 DA - 1998// TI - Cardinal manifestations of renal disease. BT - In: Harrison's Principles of Internal Medicine PB - McGraw-Hill CY - New York ID - Denker1998 ER - TY - JOUR AU - Lewis, E. J. AU - Hunsicker, L. G. AU - Clarke, W. R. AU - Berl, T. AU - Pohl, M. A. AU - Lewis, J. B. AU - Ritz, E. AU - Atkins, R. C. AU - Rohde, R. AU - Raz, I. PY - 2001 DA - 2001// TI - Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa011303 DO - 10.1056/NEJMoa011303 ID - Lewis2001 ER - TY - JOUR PY - 2000 DA - 2000// TI - Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. JO - Lancet VL - 355 UR - https://doi.org/10.1016/S0140-6736(99)12323-7 DO - 10.1016/S0140-6736(99)12323-7 ID - ref15 ER - TY - JOUR AU - Lindholm, L. H. AU - Dahlöf, B. AU - Devereux, R. B. AU - Kjeldsen, S. E. AU - Julius, S. AU - Beevers, G. AU - de Faire, U. AU - Fyhrquist, F. AU - Ibsen, H. AU - Kristiansson, K. PY - 2002 DA - 2002// TI - Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. JO - Lancet VL - 359 UR - https://doi.org/10.1016/S0140-6736(02)08089-3 DO - 10.1016/S0140-6736(02)08089-3 ID - Lindholm2002 ER -